Brian Abeysekera
Keine laufenden Positionen mehr
Profil
Brian Abeysekera has been Vice President-Marketing of Molecular Insight Pharmaceuticals, Inc. since April 2007.
He has over 20 years of experience in radioisotope and radiopharmaceutical development, including production, radiochemistry, quality control, quality assurance and regulatory affairs activities in the United States and Canada.
Previously, he served as Director of Applied Research and Development MDS Nordion, Inc. Dr. Abeysekera received a PhD in Synthetic Organic Chemistry from the University of British Columbia.
Ehemalige bekannte Positionen von Brian Abeysekera
Unternehmen | Position | Ende |
---|---|---|
MDS Nordion, Inc.
MDS Nordion, Inc. Pharmaceuticals: OtherHealth Technology MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Brian Abeysekera
University of British Columbia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
MDS Nordion, Inc.
MDS Nordion, Inc. Pharmaceuticals: OtherHealth Technology MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada. | Health Technology |